VK Sharma, Head - PCG and Capital Market Strategy at HDFC Securities recommends buying Cipla, Sun Pharmaceutical Industries, Mahindra & Mahindra Financial Services, Tata Chemicals and Vedanta and advises a bull spread in Tata Communications.
According to Technical Analyst Prakash Gaba of prakashgaba.com, the crucial support for the Nifty is at 10150 and the resistance is at 10315-10537. On the other hand, Bank Nifty has support at 25000 and resistance at 24534.
Mitessh Thakkar of miteshthacker.com recommends buying Federal Bank, Bajaj Auto, Mahindra & Mahindra and Sun Pharma.
Nifty added on to its morning gains on Thursday with the index inching up 47.45 points at 10,032.80 while the Sensex added 132.86 points at 31,966. Vedanta, Lupin, Sun Pharma along with TCS were some of the top gainers in the Nifty.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can sell Can Fin Home and Cummins India and can buy Bharti Infratel and Havells India.
The midcap index was the outperforming sector in the early hours of trade led by Biocon, Bharat Financial Inclusion, JSW Energy and Hindustan Zinc while Bharti Infratel followed by Hindalco Industries and Sun Pharmaceutical Industries were the top gainers.
Sun Pharmaceutical Industries gets a breather; a sign of relief after the US Food and Drug Administration (US FDA) closed the inspection and gave a clean chit to their Dadra unit.
Sun Pharma and Lupin are on the radar of investors on Thursday.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Sun Pharma and Escorts and can sell Indiabulls Real Estate, United Spirits and Strides Shasun.
Chandan Taparia of Motilal Oswal Securities is of the view that one can buy Bajaj Finance and TVS Motor Company while he feels that Sun Pharmaceutical Industries is likely to test Rs 560.
Sun Pharma, Sobha and Tata Motors, among others, are being tracked by investors on Monday.
Sandeep Wagle of powermywealth.com suggests buying Ceat and Sun Pharmaceutical Industries.
Mitessh Thakkar of miteshthacker.com recommends buying Sun Pharma and Escorts.
Shahina Mukadam, Independent Market Expert is of the view that one may hold Sun Pharmaceutical Industries.
Rajat Bose of rajatkbose.com is of the view that one may buy Sun Pharmaceutical Industries.
Natco Pharma rallies in trade as Mylan gets US Food and Drug Administration (US FDA) nod for Copaxone. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities spoke about the impact and his strategy on the stock.
Ashwani Gujral of ashwanigujral.com advises holding Future Consumer with a stop loss at Rs 50.
Moneycontrol attempts to identify stocks that wise investors should use to duck and weave through this particular storm.
Mitessh Thakkar of mitesshthakkar.com advises selling Dalmia Bharat and Eicher Motors.
Sharmila Joshi of sharmilajoshi.com is of the view that is of the view that one may prefer Glenmark Pharma, Sun Pharmaceutical and Lupin.
Ashwani Gujral of ashwanigujral.com suggests buying Lupin, NBCC and Dewan Housing Finance.
Ashwani Gujral of ashwanigujral.com suggests buying IndusInd Bank, Raymond and CESC and advises holding Yes Bank.
Basant Maheshwari of Basant Maheshwari Wealth is of the view that pharma should be looked at but advises starting from the top notch companies, the bluechips.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can sell MRF, Interglobe Aviation, Amara Raja Batteries and Vedanta and buy Sun Pharmaceutical Industries.
According to Mitessh Thakkar of mitesshthakkar.com, one can sell Apollo Hospitals, Can Fin Home and ICICI Prudential Life and can buy Reliance Defence and Sun Pharma.